Stereotactic radiosurgery for craniopharyngiomas.


Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
11 2021
Historique:
received: 05 08 2021
accepted: 25 08 2021
pubmed: 15 9 2021
medline: 25 11 2021
entrez: 14 9 2021
Statut: ppublish

Résumé

The management of craniopharyngiomas is challenging, usually requiring multidisciplinary care. We evaluated the long-term clinical and radiologic outcomes of Gamma Knife radiosurgery (GKRS) for craniopharyngiomas. This retrospective study involved patients managed with GKRS for a craniopharyngioma during the period of 1989 to 2019. Patient clinical and radiologic data, tumor characteristics, and procedural details were analyzed. Thirty-eight consecutive patients (24 males; mean patient age at GKRS = 30.82 years [SD ± 20.45 years]) were treated with GKRS for craniopharyngioma. Overall survival rates at 5 and 10 years were 84.1% and 80.1%, respectively. Progression-free survival at 5 years was 48.1%, and, at 10 years, it was 29.8%. Risk factors for post-GKRS clinical deterioration were increasing number of isocenters used (p = 0.04 (HR1.32, CI 1-1.73)), increasing margin dose [p = 0.02 (HR1.52, CI 1.31-1.84)], and maximum dose > 35 Gy [p = 0.002 (HR1.35, CI 1.11-1.63)]. Stereotactic radiosurgery (SRS) appears a safe and effective management option in selected craniopharyngioma patients. Increasing margin dose and maximum dose > 35 Gy are associated with an increased risk for post-SRS neurologic deficit. Further, well-designed studies are necessary to determine the optimal timing and SRS parameters and to identify which patients with craniopharyngioma will benefit the most from SRS.

Sections du résumé

BACKGROUND
The management of craniopharyngiomas is challenging, usually requiring multidisciplinary care. We evaluated the long-term clinical and radiologic outcomes of Gamma Knife radiosurgery (GKRS) for craniopharyngiomas.
METHODS
This retrospective study involved patients managed with GKRS for a craniopharyngioma during the period of 1989 to 2019. Patient clinical and radiologic data, tumor characteristics, and procedural details were analyzed.
RESULTS
Thirty-eight consecutive patients (24 males; mean patient age at GKRS = 30.82 years [SD ± 20.45 years]) were treated with GKRS for craniopharyngioma. Overall survival rates at 5 and 10 years were 84.1% and 80.1%, respectively. Progression-free survival at 5 years was 48.1%, and, at 10 years, it was 29.8%. Risk factors for post-GKRS clinical deterioration were increasing number of isocenters used (p = 0.04 (HR1.32, CI 1-1.73)), increasing margin dose [p = 0.02 (HR1.52, CI 1.31-1.84)], and maximum dose > 35 Gy [p = 0.002 (HR1.35, CI 1.11-1.63)].
CONCLUSION
Stereotactic radiosurgery (SRS) appears a safe and effective management option in selected craniopharyngioma patients. Increasing margin dose and maximum dose > 35 Gy are associated with an increased risk for post-SRS neurologic deficit. Further, well-designed studies are necessary to determine the optimal timing and SRS parameters and to identify which patients with craniopharyngioma will benefit the most from SRS.

Identifiants

pubmed: 34518903
doi: 10.1007/s00701-021-04990-1
pii: 10.1007/s00701-021-04990-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3201-3207

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Références

Chiou SM, Lunsford LD, Niranjan A, Kondziolka D, Flickinger JC (2001) Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy. Neuro Oncol 3(3):159–166
doi: 10.1093/neuonc/3.3.159
Chung W-Y, Pan DH-C, Shiau C-Y, Guo W-Y, Wang L-W (2000) Gamma knife radiosurgery for craniopharyngiomas. J Neurosurg 93(supplement_3):47–56
doi: 10.3171/jns.2000.93.supplement_3.0047
Dho Y-S, Kim YH, Kim JW, Park C-K, Chung H-T, Kim S-K, Paek SH, Wang K-C, Kim DG (2018) Optimal strategy of gamma knife radiosurgery for craniopharyngiomas. J Neurooncol 140(1):135–143
doi: 10.1007/s11060-018-2943-0
Effenterre RV, Boch A-L (2002) Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg 97(1):3–11
doi: 10.3171/jns.2002.97.1.0003
Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90(2):237–250
doi: 10.3171/jns.1999.90.2.0237
Gopalan R, Dassoulas K, Rainey J, Sherman JH, Sheehan JP (2008) Evaluation of the role of Gamma Knife surgery in the treatment of craniopharyngiomas. Neurosurg Focus 24(5):E5
doi: 10.3171/FOC/2008/24/5/E5
Hasegawa T, Kobayashi T, Kida Y (2010) Tolerance of the optic apparatus in single-fraction irradiation using stereotactic radiosurgery: evaluation in 100 patients with craniopharyngioma. Neurosurgery 66(4):688–694; discussion 694-695
doi: 10.1227/01.NEU.0000367554.96981.26
Hoffman HJ, Silva MD, Humphreys RP, Drake JM, Smith ML, Blaser SI (1992) Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 76(1):47–52
doi: 10.3171/jns.1992.76.1.0047
Jane JA, Laws ER (2006) Craniopharyngioma Pituitary 9(4):323–326
doi: 10.1007/s11102-006-0413-8
Kalapurakal JA, Goldman S, Hsieh YC, Tomita T, Marymont MH (2003) Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse. Med Pediatr Oncol 40(4):214–218
doi: 10.1002/mpo.10247
Karavitaki N, Brufani C, Warner JT, Adams CBT, Richards P, Ansorge O, Shine B, Turner HE, Wass JaH (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62(4):397–409
doi: 10.1111/j.1365-2265.2005.02231.x
Kim SK, Wang KC, Shin SH, Choe G, Chi JG, Cho BK (2001) Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factors. Childs Nerv Syst 17(9):531–536; discussion 537
doi: 10.1007/s003810100458
Kobayashi T, Kida Y, Mori Y, Hasegawa T (2005) Long-term results of gamma knife surgery for the treatment of craniopharyngioma in 98 consecutive cases. J Neurosurg 103(6 Suppl):482–488
pubmed: 16383245
Kobayashi T, Tsugawa T, Hatano M, Hashizume C, Mori Y, Shibamoto Y (2015) Gamma knife radiosurgery of craniopharyngioma: results of 30 cases treated at Nagoya Radiosurgery Center. Nagoya J Med Sci 77(3):447–454
pubmed: 26412891 pmcid: 4574332
Lee C-C, Yang H-C, Chen C-J, Hung Y-C, Wu H-M, Shiau C-Y, Guo W-Y, Pan DH-C, Chung W-Y, Liu K-D (2014) Gamma Knife surgery for craniopharyngioma: report on a 20-year experience. J Neurosurg 121(Suppl):167–178
doi: 10.3171/2014.8.GKS141411
Lin LL, Naqa IE, Leonard JR, Park TS, Hollander AS, Michalski JM, Mansur DB (2008) Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatr 1(2):126–130
doi: 10.3171/PED/2008/1/2/126
Losa M, Pieri V, Bailo M, Gagliardi F, Barzaghi LR, Gioia L, Del Vecchio A, Bolognesi A, Mortini P (2018) Single fraction and multisession Gamma Knife radiosurgery for craniopharyngioma. Pituitary 21(5):499–506
doi: 10.1007/s11102-018-0903-5
Maira G, Anile C, Rossi GF, Colosimo C (1995) Surgical treatment of craniopharyngiomas: an evaluation of the transsphenoidal and pterional approaches. Neurosurgery 36(4):715–724
doi: 10.1227/00006123-199504000-00012
Müller HL (2014) Craniopharyngioma. Endocr Rev 35(3):513–543
doi: 10.1210/er.2013-1115
Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera J-P, Puget S (2019) Craniopharyngioma. Nat Rev Dis Primers 5(1):1–19
doi: 10.1038/s41572-019-0125-9
Niranjan A, Kano H, Mathieu D, Kondziolka D, Flickinger JC, Lunsford LD (2010) Radiosurgery for craniopharyngioma. Int J Radiat Oncol Biol Phys 78(1):64–71
doi: 10.1016/j.ijrobp.2009.07.1693
Ogino A, Lunsford LD, Long H, Johnson S, Faramand A, Niranjan A, Flickinger JC, Kano H (2021) Stereotactic radiosurgery as the primary management for patients with Koos grade IV vestibular schwannomas. J Neurosurg 1(aop):1–9
doi: 10.3171/2020.8.JNS201832
Ogino A, Niranjan A, Kano H, Flickinger JC, Lunsford LD (2021) Optimizing stereotactic radiosurgery in patients with recurrent or residual craniopharyngiomas. J Neurooncol. https://doi.org/10.1007/s11060-021-03806-7
doi: 10.1007/s11060-021-03806-7 pubmed: 34286414
Saleem MA, Hashim ASM, Rashid A, Ali M (2013) Role of gamma knife radiosurgery in multimodality management of craniopharyngioma. Acta Neurochir Suppl 116:55–60
pubmed: 23417459
Schoenfeld A, Pekmezci M, Barnes MJ et al (2012) The superiority of conservative resection and adjuvant radiation for craniopharyngiomas. J Neurooncol 108(1):133–139
doi: 10.1007/s11060-012-0806-7
Stripp DCH, Maity A, Janss AJ et al (2004) Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys 58(3):714–720
doi: 10.1016/S0360-3016(03)01570-0
Tsugawa T, Kobayashi T, Hasegawa T et al (2020) Gamma Knife surgery for residual or recurrent craniopharyngioma after surgical resection: a multi-institutional retrospective study in Japan. Cureus 12(2):e6973
pubmed: 32201653 pmcid: 7075476
Ulfarsson E, Lindquist C, Roberts M, Rähn T, Lindquist M, Thorén M, Lippitz B (2002) Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients. J Neurosurg 97(5 Suppl):613–622
doi: 10.3171/jns.2002.97.supplement_5.0613
Varlotto J, DiMaio C, Grassberger C et al (2016) Multi-modality management of craniopharyngioma: a review of various treatments and their outcomes. Neurooncol Pract 3(3):173–187
pubmed: 31386091
Xu Z, Yen C-P, Schlesinger D, Sheehan J (2011) Outcomes of Gamma Knife surgery for craniopharyngiomas. J Neurooncol 104(1):305–313
doi: 10.1007/s11060-010-0494-0
Yang I, Sughrue ME, Rutkowski MJ, Kaur R, Ivan ME, Aranda D, Barani IJ, Parsa AT (2010) Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus 28(4):E5
doi: 10.3171/2010.1.FOCUS09307

Auteurs

Stylianos Pikis (S)

Department of Neurological Surgery, University of Virginia Health System, Box 800212, Charlottesville, VA, 22908, USA.

Georgios Mantziaris (G)

Department of Neurological Surgery, University of Virginia Health System, Charlottesville, VA, USA.

Karen Lavezzo (K)

Department of Neurological Surgery, University of Virginia Health System, Charlottesville, VA, USA.

Nisha Dabhi (N)

Department of Neurological Surgery, University of Virginia Health System, Charlottesville, VA, USA.

Jason Sheehan (J)

Department of Neurological Surgery, University of Virginia Health System, Box 800212, Charlottesville, VA, 22908, USA. jsheehan@virginia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH